A Phase 1 interventional study of Fimasartan/Atorvastatin Combination Tablet and Fimasartan in Hypertension and Hyperlipidemia, sponsored by Boryung Pharmaceutical Co., Ltd. Completed at 1 site in South Korea. Open to male participants aged 19 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-02-25.
Sponsored by Boryung Pharmaceutical Co., Ltd · Phase 1, Interventional, and Treatment
A phase I, Open-label, Randomized, Single-dose, 2 x 2 Crossover Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet and Coadministration of Fimasartan and Atorvastatin as Individual Tablets in Healthy Male Volunteers.
6,834 studies on the registry are indexed under Hypertension; 971 are open to participants now.
This study's enrollment of 99 is close to the median of 90 across 5,095 interventional studies indexed under Hypertension.
Browse Hypertension studies →Boryung Pharmaceutical Co., Ltd is the lead sponsor of 143 studies on the registry; 23 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Subjects of Group 1 take Fimasartan and Atorvastatin Individual Tablets at 1st day as period I. And then, after wash out for 7 days, as period II, subjects of Group 1 take a Fimasartan/Atorvastatin Combination Tablet at 8th day.
Drug: Fimasartan/Atorvastatin Combination Tablet · Drug: Fimasartan · Drug: Atorvastatin
Subjects of Group 2 take a Fimasartan/Atorvastatin Combination Tablet at 1st day as period I. And then, after wash out for 7 days, as period II, subjects of Group 2 take Fimasartan and Atorvastatin Individual Tablets at 8th day.
Drug: Fimasartan/Atorvastatin Combination Tablet · Drug: Fimasartan · Drug: Atorvastatin
Maximum observed concentration(Cmax) of Fimasartan and Atorvastatin
Time frame: 0~48 hour after medication
Area under the curve(AUCt) of Fimasartan and Atorvastatin
Time frame: 0~48 hour after medication
This study is completed, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Fimasartan · Atorvastatin
Boryung Pharmaceutical Co., Ltd →